Skip to main content

MoneyWorks4Me

OneSource Specialty Pharma informs about press release

04 May 2026 Evaluate
OneSource Specialty Pharma has informed that it enclosed Press Release issued by the Company titled: OneSource Supports Second Generic Semaglutide Approval in Canada Enables commercialisation for the first two entrants in the world’s second-largest semaglutide market.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1888.50
Dr. Reddys Labs. 1380.00
Cipla 1404.05
Lupin 2013.35
Zydus Lifesciences 1200.00
View more..